APA (7th ed.) Citation

RS, S., AJ, N., J, G., T, C., R, J., SS, Y., & HP, B. (2009). Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. The Journal of clinical endocrinology and metabolism, 94(2), 545. https://doi.org/10.1210/jc.2008-1695

Chicago Style (17th ed.) Citation

RS, Struthers, Nicholls AJ, Grundy J, Chen T, Jimenez R, Yen SS, and Bozigian HP. "Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-releasing Hormone Antagonist Elagolix." The Journal of Clinical Endocrinology and Metabolism 94, no. 2 (2009): 545. https://doi.org/10.1210/jc.2008-1695.

MLA (9th ed.) Citation

RS, Struthers, et al. "Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-releasing Hormone Antagonist Elagolix." The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, 2009, p. 545, https://doi.org/10.1210/jc.2008-1695.